Viridian Therapeutics, Inc.\DE (VRDN) Shares Outstanding (2013 - 2026)

Viridian Therapeutics, Inc.\DE's Shares Outstanding (Entity) history runs 14 years deep, the most recent figure standing at $102.5 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 25.58% year-over-year to $102.5 million; the TTM figure through Mar 2026 stood at $102.5 million (up 25.58% YoY), while the FY2025 annual figure was $84.8 million, up 4.7% from the prior year.
• Shares Outstanding (Entity) for Q1 2026 stood at $102.5 million, up from $84.8 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $102.5 million in Q1 2026, with the low at $27.2 million in Q1 2022.
• The 5-year median for Shares Outstanding (Entity) is $63.8 million (2024), against an average of $60.2 million.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) surged 275.72% in 2022, then advanced 3.85% in 2025.
• Viridian Therapeutics, Inc.\DE's Shares Outstanding (Entity) stood at $32.1 million in 2022, then jumped by 39.48% to $44.8 million in 2023, then jumped by 80.97% to $81.0 million in 2024, then advanced by 4.7% to $84.8 million in 2025, then gained by 20.82% to $102.5 million in 2026.
• Business Quant data shows VRDN's Shares Outstanding (Entity) at $102.5 million in Q1 2026, $84.8 million in Q4 2025, and $82.2 million in Q3 2025.